195 related articles for article (PubMed ID: 14672949)
1. Proteasome mediates dopaminergic neuronal degeneration, and its inhibition causes alpha-synuclein inclusions.
Sawada H; Kohno R; Kihara T; Izumi Y; Sakka N; Ibi M; Nakanishi M; Nakamizo T; Yamakawa K; Shibasaki H; Yamamoto N; Akaike A; Inden M; Kitamura Y; Taniguchi T; Shimohama S
J Biol Chem; 2004 Mar; 279(11):10710-9. PubMed ID: 14672949
[TBL] [Abstract][Full Text] [Related]
2. Expression of mutant alpha-synucleins enhances dopamine transporter-mediated MPP+ toxicity in vitro.
Lehmensiek V; Tan EM; Schwarz J; Storch A
Neuroreport; 2002 Jul; 13(10):1279-83. PubMed ID: 12151787
[TBL] [Abstract][Full Text] [Related]
3. Proteasomal inhibition leads to formation of ubiquitin/alpha-synuclein-immunoreactive inclusions in PC12 cells.
Rideout HJ; Larsen KE; Sulzer D; Stefanis L
J Neurochem; 2001 Aug; 78(4):899-908. PubMed ID: 11520910
[TBL] [Abstract][Full Text] [Related]
4. Alpha-synuclein-enhanced green fluorescent protein fusion proteins form proteasome sensitive inclusions in primary neurons.
McLean PJ; Kawamata H; Hyman BT
Neuroscience; 2001; 104(3):901-12. PubMed ID: 11440819
[TBL] [Abstract][Full Text] [Related]
5. Alpha-synuclein up-regulation and aggregation during MPP+-induced apoptosis in neuroblastoma cells: intermediacy of transferrin receptor iron and hydrogen peroxide.
Kalivendi SV; Cunningham S; Kotamraju S; Joseph J; Hillard CJ; Kalyanaraman B
J Biol Chem; 2004 Apr; 279(15):15240-7. PubMed ID: 14742448
[TBL] [Abstract][Full Text] [Related]
6. Synphilin-1 degradation by the ubiquitin-proteasome pathway and effects on cell survival.
Lee G; Junn E; Tanaka M; Kim YM; Mouradian MM
J Neurochem; 2002 Oct; 83(2):346-52. PubMed ID: 12423244
[TBL] [Abstract][Full Text] [Related]
7. Inducible expression of mutant alpha-synuclein decreases proteasome activity and increases sensitivity to mitochondria-dependent apoptosis.
Tanaka Y; Engelender S; Igarashi S; Rao RK; Wanner T; Tanzi RE; Sawa A; L Dawson V; Dawson TM; Ross CA
Hum Mol Genet; 2001 Apr; 10(9):919-26. PubMed ID: 11309365
[TBL] [Abstract][Full Text] [Related]
8. Impairment of the ubiquitin-proteasome system causes dopaminergic cell death and inclusion body formation in ventral mesencephalic cultures.
McNaught KS; Mytilineou C; Jnobaptiste R; Yabut J; Shashidharan P; Jennert P; Olanow CW
J Neurochem; 2002 Apr; 81(2):301-6. PubMed ID: 12064477
[TBL] [Abstract][Full Text] [Related]
9. An in vitro model of Parkinson's disease: linking mitochondrial impairment to altered alpha-synuclein metabolism and oxidative damage.
Sherer TB; Betarbet R; Stout AK; Lund S; Baptista M; Panov AV; Cookson MR; Greenamyre JT
J Neurosci; 2002 Aug; 22(16):7006-15. PubMed ID: 12177198
[TBL] [Abstract][Full Text] [Related]
10. Active, phosphorylation-dependent mitogen-activated protein kinase (MAPK/ERK), stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK), and p38 kinase expression in Parkinson's disease and Dementia with Lewy bodies.
Ferrer I; Blanco R; Carmona M; Puig B; Barrachina M; Gómez C; Ambrosio S
J Neural Transm (Vienna); 2001; 108(12):1383-96. PubMed ID: 11810403
[TBL] [Abstract][Full Text] [Related]
11. Proteasome inhibition causes nigral degeneration with inclusion bodies in rats.
McNaught KS; Björklund LM; Belizaire R; Isacson O; Jenner P; Olanow CW
Neuroreport; 2002 Aug; 13(11):1437-41. PubMed ID: 12167769
[TBL] [Abstract][Full Text] [Related]
12. Ubiquitination of alpha-synuclein in Lewy bodies is a pathological event not associated with impairment of proteasome function.
Tofaris GK; Razzaq A; Ghetti B; Lilley KS; Spillantini MG
J Biol Chem; 2003 Nov; 278(45):44405-11. PubMed ID: 12923179
[TBL] [Abstract][Full Text] [Related]
13. Metallothionein attenuates 3-morpholinosydnonimine (SIN-1)-induced oxidative stress in dopaminergic neurons.
Sharma SK; Ebadi M
Antioxid Redox Signal; 2003 Jun; 5(3):251-64. PubMed ID: 12880480
[TBL] [Abstract][Full Text] [Related]
14. MPP+ increases alpha-synuclein expression and ERK/MAP-kinase phosphorylation in human neuroblastoma SH-SY5Y cells.
Gómez-Santos C; Ferrer I; Reiriz J; Viñals F; Barrachina M; Ambrosio S
Brain Res; 2002 May; 935(1-2):32-9. PubMed ID: 12062470
[TBL] [Abstract][Full Text] [Related]
15. UCH-L1 aggresome formation in response to proteasome impairment indicates a role in inclusion formation in Parkinson's disease.
Ardley HC; Scott GB; Rose SA; Tan NG; Robinson PA
J Neurochem; 2004 Jul; 90(2):379-91. PubMed ID: 15228595
[TBL] [Abstract][Full Text] [Related]
16. Proteasomal inhibition-induced inclusion formation and death in cortical neurons require transcription and ubiquitination.
Rideout HJ; Stefanis L
Mol Cell Neurosci; 2002 Oct; 21(2):223-38. PubMed ID: 12401444
[TBL] [Abstract][Full Text] [Related]
17. Wild-type alpha-synuclein interacts with pro-apoptotic proteins PKCdelta and BAD to protect dopaminergic neuronal cells against MPP+-induced apoptotic cell death.
Kaul S; Anantharam V; Kanthasamy A; Kanthasamy AG
Brain Res Mol Brain Res; 2005 Sep; 139(1):137-52. PubMed ID: 15978696
[TBL] [Abstract][Full Text] [Related]
18. c-Jun N-terminal kinase pathway mediates Lactacystin-induced cell death in a neuronal differentiated Neuro2a cell line.
Sang C; Kobayashi Y; Du J; Katsumo M; Adachi H; Doyu M; Sobue G
Brain Res Mol Brain Res; 2002 Dec; 108(1-2):7-17. PubMed ID: 12480174
[TBL] [Abstract][Full Text] [Related]
19. Proteasome-dependent degradation of cyclin D1 in 1-methyl-4-phenylpyridinium ion (MPP+)-induced cell cycle arrest.
Bai J; Nakamura H; Ueda S; Kwon YW; Tanaka T; Ban S; Yodoi J
J Biol Chem; 2004 Sep; 279(37):38710-4. PubMed ID: 15247282
[TBL] [Abstract][Full Text] [Related]
20. alpha-synuclein metabolism and aggregation is linked to ubiquitin-independent degradation by the proteasome.
Tofaris GK; Layfield R; Spillantini MG
FEBS Lett; 2001 Nov; 509(1):22-6. PubMed ID: 11734199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
